Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer

BACKGROUND: Neoadjuvant stereotactic body radiotherapy (SBRT) has potential applicability in the management of borderline resectable and locally-advanced pancreatic adenocarcinoma. In this series, we report the pathologic outcomes in the subset of patients who underwent surgery after neoadjuvant SBR...

詳細記述

保存先:
書誌詳細
出版年:Radiat Oncol
主要な著者: Rajagopalan, Malolan S, Heron, Dwight E, Wegner, Rodney E, Zeh, Herbert J, Bahary, Nathan, Krasinskas, Alyssa M, Lembersky, Barry, Brand, Randall, Moser, A James, Quinn, Annette E, Burton, Steven A
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2013
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4228466/
https://ncbi.nlm.nih.gov/pubmed/24175982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-8-254
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料